©The Author(s) 2025.
World J Gastroenterol. Aug 14, 2025; 31(30): 109863
Published online Aug 14, 2025. doi: 10.3748/wjg.v31.i30.109863
Published online Aug 14, 2025. doi: 10.3748/wjg.v31.i30.109863
Table 2 Tumor responses of triglyceride-glucose index < 1.58 and triglyceride-glucose index ≥ 1.58, n (%)
| Variables | Low TyG index (n = 134) | High TyG index (n = 144) | χ2 | P value |
| CR | ||||
| 0 | 133 (99.25) | 144 (100.00) | ||
| 1 | 1 (0.75) | 0 (0.00) | ||
| PR | ||||
| 0 | 105 (78.36) | 126 (87.50) | ||
| 1 | 29 (21.64) | 18 (12.50) | ||
| SD | ||||
| 0 | 78 (58.21) | 88 (61.11) | ||
| 1 | 56 (41.79) | 56 (38.89) | ||
| PD | ||||
| 0 | 86 (64.18) | 74 (51.39) | ||
| 1 | 48 (35.82) | 70 (48.61) | ||
| ORR | 4.75 | 0.029a | ||
| 0 | 104 (77.61) | 126 (87.50) | ||
| 1 | 30 (22.39) | 18 (12.50) | ||
| DCR | 4.65 | 0.031a | ||
| 0 | 48 (35.82) | 70 (48.61) | ||
| 1 | 86 (64.18) | 74 (51.39) |
- Citation: Li GC, Yao ZY, Mao HS, Han ZX. Association of triglyceride-glucose index with long-term prognosis in advanced hepatocellular carcinoma patients receiving immunotherapy and targeted therapy. World J Gastroenterol 2025; 31(30): 109863
- URL: https://www.wjgnet.com/1007-9327/full/v31/i30/109863.htm
- DOI: https://dx.doi.org/10.3748/wjg.v31.i30.109863